By Devika Patel
Knoxville, Tenn., Aug. 4 - Antigenics Inc. said it plans another $10 million private placement of shares. As previously reported, the company raised $10 million in a financing on Thursday.
The company will sell approximately 4.4 million shares at $2.28 apiece. Investors also will receive six-month warrants for approximately 2.2 million common shares, exercisable at $2.31, and four-year warrants for approximately 2 million additional shares, exercisable at $2.50.
Rodman & Renshaw, LLC is the agent.
Proceeds will be used primarily for funding key commercial and regulatory efforts.
Antigenics is a New York-based biotechnology company with a focus on cancers and infectious diseases.
| Issuer: | Antigenics Inc.
|
| Issue: | Common shares
|
| Amount: | $10 million
|
| Shares: | 4.4 million (approximate)
|
| Price: | $2.28
|
| Warrants: | For approximately 4.2 million shares
|
| Warrant expiration: | Four years (for approximately 2 million shares), six months (for approximately 2.2 million shares)
|
| Warrant strike price: | $2.50 (for approximately 2 million shares), $2.31 (for approximately 2.2 million shares)
|
| Agent: | Rodman & Renshaw, LLC
|
| Pricing date: | Aug. 4
|
| Stock symbol: | Nasdaq: AGEN
|
| Stock price: | $2.58 at close Aug. 3
|
| Market capitalization: | $176 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
